UNH
The rally hit a speed bump
UnitedHealth spent most of the year looking like the adult in the room — then it ran from $256 in March to $458.80 in July, powered in part by that fatter-than-expected Medicare Advantage payment bump. Since then? The stock has handed back 17.3% and is now trying to prove it wasn’t just a one-season wonder.
Earnings are the next referee
The company is set to report financial results on Tuesday this week, and that’s where the plot gets interesting. Investors will be watching revenue, operating profit, and EPS for clues on whether UnitedHealth’s turnaround is real or just the market squinting at a nice chart.
- Analysts are looking for Q3 revenue around $111.49 billion
- EPS is expected to jump to about $4.15 from $2.92 in Q2
- Options traders are bracing for a swing, with implied volatility up to 70%
Why your portfolio should care
This isn’t just a check-the-box quarter. UnitedHealth is the biggest health insurer in the US, which means its numbers can act like a live pulse check on Medicare Advantage margins, healthcare costs, and whether management’s guidance still has teeth.
The fact that some bulls still have targets as high as $512 tells you the Street hasn’t given up on the story. But if results disappoint, that rising wedge chart pattern everyone loves to point at could start looking less like technical astrology and more like a warning label.
Big picture: when a stock has already run hard, earnings become less of a report card and more of a referee whistle.